More from Teva
 
MPR602-Teva-Neurologybytes-AAN Article 3-Therapy 2.png

Migraine - Management

9 min

Update on Migraine Therapy

Migraine is one of the leading causes of disability worldwide.1 While the underlying pathophysiological mechanisms of migraine and other primary headache disorders are still being characterized, novel neurotherapeutics are being developed that have the potential to positively transform migraine management and reduce its burden.2

During the Hot Topics in Headaches and Related Disorders II: Migraine Pathophysiology, Brain Imaging and Therapeutic Advances at the AAN 2019 Annual Meeting in Philadelphia, Prof. Peter Goadsby (UCSF Medical Center) presented the latest advances in migraine therapy.

Log in to read this article

If you do not have a Log in, please register to be part of a big community, experience premium content and stay informed about exclusive professional events.

LOG IN

Not Registered yet ? Register now